|
1
|
Trigatti BL and Fuller M: HDL signaling
and protection against coronary artery atherosclerosis in mice. J
Biomed Res. 30:94–100. 2016.PubMed/NCBI
|
|
2
|
Cai Y, Li JD and Yan C: Vinpocetine
attenuates lipid accumulation and atherosclerosis formation.
Biochem Biophys Res Commun. 434:439–443. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsai JY, Su KH, Shyue SK, Kou YR, Yu YB,
Hsiao SH, Chiang AN, Wu YL, Ching LC and Lee TS: EGb761 ameliorates
the formation of foam cells by regulating the expression of SR-A
and ABCA1: Role of haem oxygenase-1. Cardiovasc Res. 88:415–423.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rahaman SO, Swat W, Febbraio M and
Silverstein RL: Vav family Rho guanine nucleotide exchange factors
regulate CD36-mediated macrophage foam cell formation. J Biol Chem.
286:7010–7017. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chistiakov DA, Bobryshev YV and Orekhov
AN: Macrophage-mediated cholesterol handling in atherosclerosis. J
Cell Mol Med. 20:17–28. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fielding CJ and Fielding PE: Cellular
cholesterol efflux. Biochim Biophys Acta. 1533:175–189. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McNeish J, Aiello RJ, Guyot D, Turi T,
Gabel C, Aldinger C, Hoppe KL, Roach ML, Royer LJ, de Wet J, et al:
High density lipoprotein deficiency and foam cell accumulation in
mice with targeted disruption of ATP-binding cassette
transporter-1. Proc Natl Acad Sci USA. 97:4245–4250. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kennedy MA, Barrera GC, Nakamura K, Baldán
A, Tarr P, Fishbein MC, Frank J, Francone OL and Edwards PA: ABCG1
has a critical role in mediating cholesterol efflux to HDL and
preventing cellular lipid accumulation. Cell Metab. 1:121–131.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Haghpassand M, Bourassa PA, Francone OL
and Aiello RJ: Monocyte/macrophage expression of ABCA1 has minimal
contribution to plasma HDL levels. J Clin Invest. 108:1315–1320.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao JF, Ching LC, Huang YC, Chen CY,
Chiang AN, Kou YR, Shyue SK and Lee TS: Molecular mechanism of
curcumin on the suppression of cholesterol accumulation in
macrophage foam cells and atherosclerosis. Mol Nutr Food Res.
56:691–701. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park SH, Paek JH, Shin D, Lee JY, Lim SS
and Kang YH: Purple perilla extracts with α-asarone enhance
cholesterol efflux from oxidized LDL-exposed macrophages. Int J Mol
Med. 35:957–965. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang C, Yan W, Li B, Xu B, Gong Y, Chu F,
Zhang Y, Yao Q, Wang P and Lei H: A new ligustrazine
derivative-selective cytotoxicity by suppression of NF-κB/p65 and
COX-2 expression on human hepatoma cells. Part 3. Int J Mol Sci.
16:16401–16413. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pan J, Shang JF, Jiang GQ and Yang ZX:
Ligustrazine induces apoptosis of breast cancer cells in vitro and
in vivo. J Cancer Res Ther. 11:454–458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ji AJ, Liu SL, Ju WZ and Huang XE:
Anti-proliferation effects and molecular mechanisms of action of
tetramethypyrazine on human SGC-7901 gastric carcinoma cells. Asian
Pac J Cancer Prev. 15:3581–3586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zeng Z, Zhu W, Zhou X, Jin Z, Liu H, Chen
X, Pan J, Demura H, Naruse M and Shi Y: Tetramethylpyrazine, a
Chinese drug, blocks coronary vasoconstriction by endothelin-1 and
decreases plasma endothelin-1 levels in experimental animals. J
Cardiovasc Pharmacol. 31 Suppl 1:S313–S316. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo SK, Chen KJ, Qian ZH, Weng WL and Qian
MY: Tetramethylpyrazine in the treatment of cardiovascular and
cerebrovascular diseases. Planta Med. 47:891983. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dai XZ and Bache RJ: Coronary and systemic
hemodynamic effects of tetramethylpyrazine in the dog. J Cardiovasc
Pharmacol. 7:841–849. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu SY and Sylvester DM:
Antithrombotic/antiplatelet activity of tetramethylpyrazine. Thromb
Res. 58:129–140. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ni X, Wong SL, Wong CM, Lau CW, Shi X, Cai
Y and Huang Y: Tetramethylpyrazine protects against hydrogen
peroxide-provoked endothelial dysfunction in isolated rat aortic
rings: Implications for antioxidant therapy of vascular diseases.
Evid Based Complement Alternat Med. 2014:6271812014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang GF, Shi CG, Sun MZ, Wang L, Wu SX,
Wang HF, Xu ZQ and Chen DM: Tetramethylpyrazine attenuates
atherosclerosis development and protects endothelial cells from
ox-LDL. Cardiovasc Drugs Ther. 27:199–210. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang F, Qian J, Chen S, Zhang W and Liu
C: Ligustrazine improves atherosclerosis in rat via attenuation of
oxidative stress. Pharm Biol. 49:856–863. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li XY, He JL, Liu HT, Li WM and Yu C:
Tetramethylpyrazine suppresses interleukin-8 expression in
LPS-stimulated human umbilical vein endothelial cell by blocking
ERK, p38 and nulear factor-kappaB signaling pathways. J
Ethnopharmacol. 125:83–89. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kang Q, Liu W, Liu H and Zhou M: Effect of
compound Chuanxiong capsule on inflammatory reaction and
PI3K/Akt/NF-κB signaling pathway in atherosclerosis. Evid Based
Complement Alternat Med. 2015:5845962015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu Y, Sun B, Liu K, Yan M, Zhang Y, Miao C
and Ren L: Icariin attenuates high-cholesterol diet induced
atherosclerosis in rats by inhibition of inflammatory response and
p38 MAPK signaling pathway. Inflammation. 39:228–236. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Z, Huo JR, Yang L and Zhu HY: Effect
of ligustrazine on mice model of hepatic veno-occlusive disease
induced by Gynura segetum. J Gastroenterol Hepatol. 26:1016–1021.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li XY, Kong LX, Li J, He HX and Zhou YD:
Kaempferol suppresses lipid accumulation in macrophages through the
downregulation of cluster of differentiation 36 and the
upregulation of scavenger receptor class B type I and ATP-binding
cassette transporters A1 and G1. Int J Mol Med. 31:331–338. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin YT, Jian DY, Kwok CF, Ho LT and Juan
CC: Visfatin promotes foam cell formation by dysregulating CD36,
SRA, ABCA1, and ABCG1 expression in RAW264.7 macrophages. Shock.
45:460–468. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin CS, Lin FY, Ho LJ, Tsai CS, Cheng SM,
Wu WL, Huang CY, Lian CH, Yang SP and Lai JH: PKCδ signalling
regulates SR-A and CD36 expression and foam cell formation.
Cardiovasc Res. 95:346–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang CX, Zhang YL, Wang JF, Jiang JY and
Bao JL: MCP-1 impacts RCT by repressing ABCA1, ABCG1, and SR-BI
through PI3K/Akt posttranslational regulation in HepG2 cells. J
Lipid Res. 54:1231–1240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Naik SU, Wang X, Da Silva JS, Jaye M,
Macphee CH, Reilly MP, Billheimer JT, Rothblat GH and Rader DJ:
Pharmacological activation of liver X receptors promotes reverse
cholesterol transport in vivo. Circulation. 113:90–97. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Terasaka N, Hiroshima A, Koieyama T,
Ubukata N, Morikawa Y, Nakai D and Inaba T: T-0901317, a synthetic
liver X receptor ligand, inhibits development of atherosclerosis in
LDL receptor-deficient mice. FEBS Lett. 536:6–11. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rana M, Kumar A, Tiwari RL, Singh V,
Chandra T, Dikshit M and Barthwal MK: IRAK regulates macrophage
foam cell formation by modulating genes involved in cholesterol
uptake and efflux. BioEssays. 38:591–604. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gui YZ, Yan H, Gao F, Xi C, Li HH and Wang
YP: Betulin attenuates atherosclerosis in apoE−/− mice
by up-regulating ABCA1 and ABCG1. Acta Pharmacol Sin. 37:1337–1348.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li X, Zhou Y, Yu C, Yang H, Zhang C, Ye Y
and Xiao S: Paeonol suppresses lipid accumulation in macrophages
via upregulation of the ATP-binding cassette transporter A1 and
downregulation of the cluster of differentiation 36. Int J Oncol.
46:764–774. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fu Y, Mukhamedova N, Ip S, D'Souza W,
Henley KJ, DiTommaso T, Kesani R, Ditiatkovski M, Jones L, Lane RM,
et al: ABCA12 regulates ABCA1-dependent cholesterol efflux from
macrophages and the development of atherosclerosis. Cell Metab.
18:225–238. 2013. View Article : Google Scholar : PubMed/NCBI
|
